Latent tuberculosis infection in patients with psoriasis using biologic therapies
Monaldi Archives for Chest Disease · 2025
DOI: 10.4081/monaldi.2025.3538 ↗Kurz gefasst
Fachartikel in der Zeitschrift Monaldi Archives for Chest Disease, 2025. Verfasst von Fernanda Luiza Staub und 7 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Program in Pulmonary Sciences, Federal University of Rio Grande do Sul, Porto Alegre; Dermatology Department, Porto Alegre Clinical Hosp…. Hauptthemen laut MEDLINE: Psoriasis, Latent Tuberculosis, Biological Therapy, Biological Products. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Some studies have demonstrated a high prevalence of latent tuberculosis infection (LTBI) in patients with psoriasis and a higher risk of active tuberculosis (TB) in patients with severe psoriasis. The objective of this study is to identify the prevalence of LTBI before starting treatment with different biologicals and to identify the prevalence of LTBI and active TB while using these medications. We conducted a cross-sectional study with retrospective data collection in the outpatient department of dermatology at a general, tertiary care, university-affiliated hospital. The electronic medical records of all adult patients (≥18 years old) with psoriasis undergoing treatment with biologics were reviewed, and information about psoriasis, the type of biological therapy used, and the tuberculin skin test (TST) results were collected. The patients included had an indication for the TST test according to the Ministry of Health. In total, 126 patients were included in the study. The median duration of disease was 20 years. A total of 31 patients (24.6%) had LTBI diagnosed at screening before the use of biologicals, and an additional 17 (17.9%) patients had a diagnosis of LTBI during biological therapy. There were no cases of active TB during treatment with biologicals. There was no difference in the prevalence of LTBI during treatment with tumor necrosis factor inhibitors, interleukin (IL)-17 inhibitors, IL-23 inhibitors, and IL-12/23 inhibitors (p=0.228). In conclusion, we found that 24.6% of patients with psoriasis in an endemic TB region had LTBI. Additionally, 16.8% had a diagnosis of LTBI during biological therapy. Our data corroborate the recommendation that patients who live in high TB incidence settings should be tested annually for LTBI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Postgraduate Program in Pulmonary Sciences, Federal University of Rio Grande do Sul, Porto Alegre; Dermatology Department, Porto Alegre Clinical Hospital.
- Faculty of Medicine, Federal University of Rio Grande do Sul, Porto Alegre.
- Dermatology Department, Porto Alegre Clinical Hospital.
- Postgraduate Program in Pulmonary Sciences, Federal University of Rio Grande do Sul, Porto Alegre; Faculty of Medicine, Federal University of Rio Grande do Sul, Porto Alegre; Pulmonology Department, Porto Alegre Clinica…
ORCID-Profile: Raimunda Sinthia Lima de Braga, João Vitor Vigne Duz, Gean Souza Ramos
Zitieren
APA
Staub, F. L., Santos, A. K., Lima de Braga, R. S., Scheffer de Souza, M., Vigne Duz, J. V., Souza Ramos, G., Catucci Boza, J., & Rossato Silva, D. (2025). Latent tuberculosis infection in patients with psoriasis using biologic therapies. Monaldi Archives for Chest Disease. https://doi.org/10.4081/monaldi.2025.3538
Vancouver
Staub FL, Santos AK, Lima de Braga RS, Scheffer de Souza M, Vigne Duz JV, Souza Ramos G, et al. Latent tuberculosis infection in patients with psoriasis using biologic therapies. Monaldi Archives for Chest Disease. 2025. doi:10.4081/monaldi.2025.3538
BibTeX
@article{Staub2025,
author = {Staub, Fernanda Luiza and Santos, André Kulzer and Lima de Braga, Raimunda Sinthia and Scheffer de Souza, Marina and Vigne Duz, João Vitor and Souza Ramos, Gean and Catucci Boza, Juliana and Rossato Silva, Denise},
title = {Latent tuberculosis infection in patients with psoriasis using biologic therapies},
journal = {Monaldi Archives for Chest Disease},
year = {2025},
doi = {10.4081/monaldi.2025.3538}
}
EUVIMED